Medicare prescription drug plan premiums to average 11 percent rise in 2010

Premiums for Medicare Part D plans will rise an average of 11 percent next year, the Milwaukee Journal Sentinel reports. The cost for all Medicare prescription plans has increased 50 percent nationally since 2006. "Premiums are just one piece of the total cost. More important is the cost of specific drugs that people take. That can vary from plan to plan and can change from one year to the next. So, too, do people's medications. A different plan, for example, may have a lower price for a new prescription. Sifting through all the variables is nearly impossible without a computer. ... A relatively small percentage of people have switched plans, according to a study published last summer in the New England Journal of Medicine. That could indicate that people are happy with their plans. But it also could indicate that shopping for the best plan is just too much trouble" (Boulton, 11/30).


Kaiser Health NewsThis article was reprinted from khn.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Medicare coverage for obesity drug raises questions